Structure‐based Discovery and Redesign of TGF‐β1 Elbow Epitope Recognition by Its Type‐ii Receptor in Hypertrophic Scarring Biotherapy

Xiaoting Chen,Huixiong Wang,Songlin Yang,Jianghong Zheng,Xiangdong Liu,Guangyu Mao

DOI: https://doi.org/10.1002/jmr.2881

2020-01-01

Abstract:Transforming growth factor-beta 1 (TGF-beta 1) signaling pathway has been implicated in the fibroblast activation of hypertrophic scarring (HS). Previously, we proposed a new biotherapeutic strategy to combat HS by disrupting the intermolecular interaction of TGF-beta 1 with its cognate type-II receptor (T beta R-II). Here, we further demonstrate that the binding site of TGF-beta 1 to T beta R-II is not overlapped with the conformational wrist epitope and linear knuckle epitope that are traditionally recognized as the functional binding sites of bone morphogenetic protein-2 (BMP-2) to its type-II receptor (BMPR-II), which can thus be regarded as a new functional site we called elbow epitope. Structural, energetic, and dynamic investigations reveal that the elbow epitope consists of two sequentially discontinuous, spatially vicinal segments Loop(30-34) and Turn(90-95); they cannot work effectively to independently interact with T beta R-II. Rational redesign of the epitope is performed using an integrated in silio-in vitro method based on crystal and modeled structure data. In the procedure, the two epitope segments are split from the interface of TGF-beta 1-T beta R-II complex and then connected with each other in a head-to-tail manner by adding a flexible poly-(Gly)n linker between them, thus resulting in a series of combined peptides. We found that the peptide affinity reaches maximum at n = 2, which shares a consistent binding mode with the elbow epitope at native complex interface. The linker of either too long (n > 2) or too short (n < 2) cannot properly place the gap space between the two segments, thus impairing the binding compatibility of designed peptides with T beta R-II active site.